| 論文種別 | 原著(症例報告除く) |
| 言語種別 | 英語 |
| 査読の有無 | その他(不明) |
| 表題 | Clinical Outcomes and Histologic Findings of Patients With Hepatocellular Carcinoma With Durable Partial Response or Durable Stable Disease After Receiving Atezolizumab Plus Bevacizumab |
| 掲載誌名 | 正式名：Journal of clinical oncology 略 称：J Clin Oncol ISSNコード：0732183X/15277755 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 42(34),pp.4060-4070 |
| 著者・共著者 | Shen YC, Liu TH, Nicholas A, Soyama A, Yuan CT, Chen TC, Eguchi S, Yoshizumi
T, Itoh S, Nakamura N, Kosaka H, Kaibori M, Ishii T, Hatano E, Ogawa C, Naganuma A, Kakizaki S, Cheng CH, Lin PT, Su YY, Chuang CH, Lu LC, Wu CJ, Wang HW, Rau KM, Hsu CH, Lin SM, Huang YH, Hernandez S, Finn RS, Kudo M, Cheng AL. |
| 発行年月 | 2024/12 |
| DOI | 10.1200/JCO.24.00645 |
| PMID | 39197119 |